Research programme: combrestatin analogues - sigma-tauAlternative Names: ST 2151; ST 2179; ST 2303; ST 2495; ST 2496; ST 2966; ST 2969; ST 2971; ST 2996; ST 3038
Latest Information Update: 29 Sep 2010
At a glance
- Originator sigma-tau SpA
- Class Benzofurans; Benzyl compounds; Stilbenes
- Mechanism of Action Tubulin polymerisation inhibitors; Vascular disrupting agents
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 06 May 2005 Preclinical trials in Cancer in Italy (unspecified route)